• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Centricity Vision’s new ZEPTO Plus handpiece gives surgeons a choice in capsulotomy size


CEO Rob Thornhill discusses the features of the device, as well as plans for a new technology called ZEPTOLINK which combines the company’s novel ZEPTO technology with any phaco device.

Video transcript

Note: This transcript has been lightly edited for clarity.

Rob Thornhill: Hello, my name is Rob Thornhill. I'm the CEO of Centricity Vision. We're pleased to announce the introduction of our new ZEPTO Plus handpiece at this year's [American] Academy [of Ophthalmology]. ZEPTO Plus gives our surgeon partners a choice in capsulotomy size when they're working with our automated capsulotomy system.

The ZEPTO Plus creates a 5.4 capsulotomy and allows surgeons to do phaco outside of the capsular bag and also provides a larger capsulotomy for surgeons when they do complex cases. This device provides the same centered, consistent capsulotomies with 360-degree overlap that provides time and cost efficiency in the operating room.

We're also developing a new technology called ZEPTOLINK which combines our ZEPTO technology with any phaco device. This device, when it's completed, will add complete control for the surgeon and the procedure including the capsulotomy through the phaco foot pedal. We are going to the FDA by the end of this year, and we expect if all things go well to be introducing this very exciting new technology by spring 2023.

Related Videos
EyeCon 2024: Peter J. McDonnell, MD, marvels on mentoring, modern technology, and ophthalmology’s future
© 2024 MJH Life Sciences

All rights reserved.